KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Feb 03, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 31, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 30, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 29, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 28, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 27, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 24, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 23, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 22, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 21, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 17, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 16, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 15, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 14, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 13, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 10, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 09, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 08, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 07, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 06, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 03, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Jan 02, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Dec 31, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Dec 30, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Dec 27, 2019 $0.0536 $0.0536 $0.0536 $0.0536 0
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT